Results 11 to 20 of about 16,223 (208)

Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy

NeuroImage: Clinical, 2021
Progressive supranuclear palsy is a neurodegenerative disorder characterized primarily by tau inclusions and neurodegeneration in the midbrain, basal ganglia, thalamus, premotor and frontal cortex.
Irene Sintini, Kenton Kaufman, Hugo Botha, Peter R. Martin, Stacy R. Loushin, Matthew L. Senjem, Robert I. Reid, Christopher G. Schwarz, Clifford R. Jack Jr, Val J. Lowe, Keith A. Josephs, Jennifer L. Whitwell, Farwa Ali   +12 more
doaj   +1 more source

The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes

Diagnostics, 2022
Progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS) are clinical manifestations of tauopathic Parkinsonian syndromes. Due to their overlapping symptomatology, the differential diagnosis of these entities may be difficult when ...
Piotr Alster, Natalia Madetko, Bartosz Migda, Michał Nieciecki, Michał Kutyłowski, Leszek Królicki, Andrzej Friedman   +6 more
doaj   +1 more source

9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease

NeuroImage: Clinical, 2017
Background: The anatomy of the substantia nigra on conventional MRI is controversial. Even using histological techniques it is difficult to delineate with certainty from surrounding structures.
LA Massey, MA Miranda, O Al-Helli, HG Parkes, JS Thornton, P-W So, MJ White, L Mancini, C Strand, J Holton, AJ Lees, T Revesz, TA Yousry   +12 more
doaj   +1 more source

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.

PLoS ONE, 2019
Radiological biomarkers have been reported for multiple system atrophy and progressive supranuclear palsy, but serum/plasma biomarkers for each disorder have not been established.
Akio Mori, Kei-Ichi Ishikawa, Shinji Saiki, Taku Hatano, Yutaka Oji, Ayami Okuzumi, Motoki Fujimaki, Takahiro Koinuma, Shin-Ichi Ueno, Yoko Imamichi, Nobutaka Hattori   +10 more
doaj   +1 more source

A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.

PLoS ONE, 2013
ObjectiveWe studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials ...
Boyd C P Ghosh, Roger H S Carpenter, James B Rowe   +2 more
doaj   +1 more source

Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults

BMC Neurology, 2012
Background Progressive supranuclear palsy and Parkinson’s disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to analyze the gait of people with progressive supranuclear palsy (
Egerton Thorlene, Williams David R, Iansek Robert   +2 more
doaj   +1 more source

Diplopia in Progressive Supranuclear Palsy [PDF]

Movement Disorders Clinical Practice, 2020
View Supplementary Video 1View Supplementary Video ...
Narges, Yazdi, Mona Ramezani, Ghamsari, Ali, Shoeibi, Mohammad, Rohani   +3 more
openaire   +2 more sources

Clinical features of progressive supranuclear palsy

Frontiers in Aging Neuroscience, 2023
BackgroundProgressive supranuclear palsy (PSP) is a clinically heterogenous atypical parkinsonian syndrome. Therefore, early recognition and correct diagnosis of PSP is challenging but essential.
Yafei Wen, Qijie Yang, Bin Jiao, Bin Jiao, Bin Jiao, Bin Jiao, Bin Jiao, Weiwei Zhang, Jingyi Lin, Yuan Zhu, Qian Xu, Qian Xu, Hui Zhou, Ling Weng, Ling Weng, Xinxin Liao, Yafang Zhou, Junling Wang, Jifeng Guo, Jifeng Guo, Jifeng Guo, Jifeng Guo, Xinxiang Yan, Xinxiang Yan, Xinxiang Yan, Xinxiang Yan, Hong Jiang, Beisha Tang, Beisha Tang, Beisha Tang, Beisha Tang, Lu Shen, Lu Shen, Lu Shen, Lu Shen, Lu Shen, Lu Shen   +36 more
doaj   +1 more source

Accuracy of MR markers for differentiating Progressive Supranuclear Palsy from Parkinson's disease

NeuroImage: Clinical, 2016
Background: Advanced brain MR techniques are useful tools for differentiating Progressive Supranuclear Palsy from Parkinson's disease, although time-consuming and unlikely to be used all together in routine clinical work.
Stefano Zanigni, Giovanna Calandra-Buonaura, David Neil Manners, Claudia Testa, Dino Gibertoni, Stefania Evangelisti, Luisa Sambati, Maria Guarino, Patrizia De Massis, Laura Ludovica Gramegna, Claudio Bianchini, Paola Rucci, Pietro Cortelli, Raffaele Lodi, Caterina Tonon   +14 more
doaj   +1 more source

Methods and utility of quantitative brainstem measurements in progressive supranuclear palsy versus Parkinson's disease in a routine clinical setting

Clinical Parkinsonism & Related Disorders, 2020
Background and Purpose: The clinical diagnosis of progressive supranuclear palsy can be challenging, as the clinical presentation overlaps with that of Parkinson's disease and multiple system atrophy.
Jessica Cooperrider, Brent Bluett, Stephen E. Jones   +2 more
doaj   +1 more source